Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-γ-dependent way

Baker, 1990, Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice, J. Neuroimmunol., 28, 261, 10.1016/0165-5728(90)90019-J Becher, 2002, Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12, J. Clin. Invest., 110, 493, 10.1172/JCI0215751 Bettelli, 1998, IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice, J. Immunol., 161, 3299, 10.4049/jimmunol.161.7.3299 Billiau, 1996, Interferon-γ: biology and role in pathogenesis, Adv. Immunol., 62, 61, 10.1016/S0065-2776(08)60428-9 Billiau, 1988, Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ, J. Immunol., 140, 1506, 10.4049/jimmunol.140.5.1506 Billiau, 2000, The role of interferon-γ in experimental autoimmune disease, 300 Bright, 1998, Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis, J. Neuroimmunol., 82, 22, 10.1016/S0165-5728(97)00184-7 Brown, 1981, Relapsing experimental allergic encephalomyelitis in the SJL/J mouse, Lab. Invest., 45, 278 Chu, 2000, Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis, J. Exp. Med., 192, 123, 10.1084/jem.192.1.123 Collins, 1995, Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo, J. Exp. Med., 182, 1169, 10.1084/jem.182.4.1169 Constantinescu, 1998, Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis, J. Immunol., 161, 5097, 10.4049/jimmunol.161.9.5097 Constantinescu, 2001, Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively, Clin. Immunol., 98, 23, 10.1006/clim.2000.4944 Cua, 1999, Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis, J. Exp. Med., 189, 1005, 10.1084/jem.189.6.1005 Cua, 2003, Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain, Nature, 421, 744, 10.1038/nature01355 Dalton, 1993, Multiple defects of immune cell function in mice with disrupted interferon-gamma genes, Science, 259, 1739, 10.1126/science.8456300 Di Rosa, 1998, Lack of Th2 cytokine increase during spontaneous remission of experimental allergic encephalomyelitis, Eur. J. Immunol., 28, 3893, 10.1002/(SICI)1521-4141(199812)28:12<3893::AID-IMMU3893>3.0.CO;2-# Dijkmans, 1991, Murine interferon-γ/interleukin-1 fusion protein used as antigens for the generation of hybridomas producing monoclonal anti-interleukin-1 antibodies, Cytokine, 3, 134, 10.1016/1043-4666(91)90034-B Duong, 1992, Effect of interferon-gamma on myelin basic protein-specific T cell line proliferation in response to antigen-pulsed accessory cells, Cell. Immunol., 145, 311, 10.1016/0008-8749(92)90334-L Duong, 1992, Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse, J. Neuroimmunol., 36, 105, 10.1016/0165-5728(92)90042-J Duong, 1994, Effect of anti-interferon-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains, J. Neuroimmunol., 53, 101, 10.1016/0165-5728(94)90069-8 Ferber, 1996, Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE), J. Immunol., 156, 5, 10.4049/jimmunol.156.1.5 Germann, 1993, Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells, Eur. J. Immunol., 23, 1762, 10.1002/eji.1830230805 Germann, 1995, Administration of interleukin-12 in combination with type II collagen induces severe arthritis in DBA/1 mice, Proc. Natl. Acad. Sci. U. S. A., 92, 4823, 10.1073/pnas.92.11.4823 Gerosa, 1996, Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10, J. Exp. Med., 183, 2559, 10.1084/jem.183.6.2559 Gran, 2004, Early administration of IL-12 suppresses EAE through induction of interferon-gamma, J. Neuroimmunol., 156, 123, 10.1016/j.jneuroim.2004.07.019 Gran, 2002, IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination, J. Immunol., 169, 7104, 10.4049/jimmunol.169.12.7104 Harrington, 2005, Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, Nat. Immunol., 6, 1123, 10.1038/ni1254 Heremans, 1987, Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide, J. Immunol., 138, 4175, 10.4049/jimmunol.138.12.4175 Heremans, 1996, Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against IFN-γ, Eur. J. Immunol., 26, 2393, 10.1002/eji.1830261019 Heremans, 1999, Role of endogenous interleukin-12 (IL-12) in induced and spontaneous relapses of experimental autoimmune encephalomyelitis in mice, Eur. Cytokine Netw., 10, 171 Hess, 1996, High doses of interleukin-12 inhibit the development of joint disease in DBA/1mice immunized with type II collagen in complete Freund's adjuvant, Eur. J. Immunol., 26, 187, 10.1002/eji.1830260129 Hong, 2005, Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3, Proc. Natl. Acad. Sci. U. S. A., 102, 6449, 10.1073/pnas.0502187102 Ichikawa, 2000, Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing–remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide, J. Neuroimmunol., 102, 56, 10.1016/S0165-5728(99)00153-8 Issazadeh, 1995, Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β, J. Neuroimmunol., 61, 205, 10.1016/0165-5728(95)00100-G Issazadeh, 1996, Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-β, J. Neuroimmunol., 69, 103, 10.1016/0165-5728(96)00076-8 Kawakami, 2005, Autoimmune CD4+ T cell memory: lifelong persistence of encephalitogenic T cell clones in healthy immune repertoires, J. Immunol., 175, 69, 10.4049/jimmunol.175.1.69 Kelchtermans, 2005, Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma, Arthritis Res. Ther., 7, R402, 10.1186/ar1500 Kohm, 2002, Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis, J. Immunol., 169, 4712, 10.4049/jimmunol.169.9.4712 Kozlowski, 1987, Induction of synchronized relapses in SJL/J mice with chronic relapsing experimental allergic encephalomyelitis, Acta Neuropathol., 74, 163, 10.1007/BF00692847 Krakowski, 1996, Interferon-γ confers resistance to experimental allergic encephalomyelitis, Eur. J. Immunol., 26, 1641, 10.1002/eji.1830260735 Kuroda, 1991, Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats, J. Neuroimmunol., 34, 159, 10.1016/0165-5728(91)90125-Q Lafaille, 1997, Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease, J. Exp. Med., 186, 307, 10.1084/jem.186.2.307 Lenardo, 1991, Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis, Nature, 353, 858, 10.1038/353858a0 Leonard, 1995, Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12, J. Exp. Med., 181, 381, 10.1084/jem.181.1.381 Leonard, 1996, Regulation of experimental autoimmune encephalomyelitis by interleukin-12, Ann. N.Y. Acad. Sci., 795, 216, 10.1111/j.1749-6632.1996.tb52671.x Lublin, 1993, Monoclonal anti-γ interferon antibodies enhance experimental allergic encephalomyelitis, Autoimmunity, 16, 267, 10.3109/08916939309014645 Macatonia, 1995, Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells, J. Immunol., 154, 5071, 10.4049/jimmunol.154.10.5071 Manetti, 1993, Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing cells, J. Exp. Med., 177, 1199, 10.1084/jem.177.4.1199 Martin, 1992, Immunological aspects of demyelinating diseases, Annu. Rev. Immunol., 10, 153, 10.1146/annurev.iy.10.040192.001101 Martin, 1995, Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein, Exp. Neurol., 131, 221, 10.1016/0014-4886(95)90044-6 McGeachy, 2005, Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system, J. Immunol., 175, 3025, 10.4049/jimmunol.175.5.3025 McKnight, 1994, Effects of IL-12 on helper T cell-dependent immune responses in vivo, J. Immunol., 152, 2172, 10.4049/jimmunol.152.5.2172 Mendel, 1995, A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells, Eur. J. Immunol., 25, 1951, 10.1002/eji.1830250723 Mokhtarian, 1984, Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice, Nature, 309, 356, 10.1038/309356a0 Montero, 2004, Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies, J. Autoimmun., 23, 1, 10.1016/j.jaut.2004.05.001 Morris, 1994, Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection, J. Immunol., 152, 1047, 10.4049/jimmunol.152.3.1047 O'Hara, 1996, Prevention of a Th1 disease by a Th1 cytokine: IL-12 and diabetes in NOD mice, Ann. N.Y. Acad. Sci., 795, 241, 10.1111/j.1749-6632.1996.tb52673.x Olsson, 1995, Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis, Immunol. Rev., 144, 245, 10.1111/j.1600-065X.1995.tb00072.x Oppmann, 2000, Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12, Immunity, 13, 715, 10.1016/S1074-7613(00)00070-4 Owens, 1995, The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis, Neurol. Clin., 13, 51, 10.1016/S0733-8619(18)30061-6 Park, 2005, A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17, Nat. Immunol., 6, 1133, 10.1038/ni1261 Petitto, 2000, Interleukin-2 gene deletion produces a robust reduction in susceptibility to experimental autoimmune encephalomyelitis in C57BL/6 mice, Neurosci. Lett., 285, 66, 10.1016/S0304-3940(00)00996-4 Refaeli, 1998, Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis, Immunity, 8, 615, 10.1016/S1074-7613(00)80566-X Ruddle, 1990, An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis, J. Exp. Med., 172, 1193, 10.1084/jem.172.4.1193 Segal, 1996, IL-12 unmasks latent autoimmune disease in resistant mice, J. Exp. Med., 184, 771, 10.1084/jem.184.2.771 Segal, 1997, Microbial products induce autoimmune disease by an IL-12-dependent pathway, J. Immunol., 158, 5087, 10.4049/jimmunol.158.11.5087 Segal, 1998, An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease, J. Exp. Med., 187, 537, 10.1084/jem.187.4.537 Selmaj, 1991, Anti-tumor necrosis factor therapy abrogates autoimmune demyelination, Ann. Neurol., 30, 694, 10.1002/ana.410300510 Smith, 1997, IL-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat, Am. J. Pathol., 150, 1909 Swain, 1990, IL-4 directs the development of Th2-like helper effectors, J. Immunol., 145, 3796, 10.4049/jimmunol.145.11.3796 Tanuma, 1997, Competitive PCR quantification of pro- and anti-inflammatory cytokine mRNA in the central nervous system during autoimmune encephalomyelitis, J. Neuroimmunol., 73, 197, 10.1016/S0165-5728(96)00199-3 Tarrant, 1998, Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis, J. Immunol., 161, 122, 10.4049/jimmunol.161.1.122 Tarrant, 1999, Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis, J. Exp. Med., 189, 219, 10.1084/jem.189.2.219 Trinchieri, 1995, Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity, Annu. Rev. Immunol., 13, 251, 10.1146/annurev.iy.13.040195.001343 van der Veen, 1993, Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10, J. Neuroimmunol., 48, 213, 10.1016/0165-5728(93)90194-4 Voorthuis, 1990, Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-γ in rats, Clin. Exp. Immunol., 81, 183, 10.1111/j.1365-2249.1990.tb03315.x Waldburger, 1996, Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12—preferential expansion of interferon-γ-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms, Am. J. Pathol., 148, 375 Weir, 2003, IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis, Int. Immunol., 15, 1283, 10.1093/intimm/dxg127 Wensky, 2001, The role of IFN-gamma in the production of Th2 subpopulations: implications for variable Th2-mediated pathologies in autoimmunity, J. Immunol., 167, 3074, 10.4049/jimmunol.167.6.3074 Willenborg, 1996, IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis, J. Immunol., 157, 3223, 10.4049/jimmunol.157.8.3223 Windhagen, 1996, IL-12 induces human T cells secreting IL-10 with IFN-γ, J. Immunol., 157, 1127, 10.4049/jimmunol.157.3.1127 Wu, 2002, Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo, Nat. Immunol., 3, 852, 10.1038/ni832 Xu, 1997, Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis, Cell. Immunol., 178, 69, 10.1006/cimm.1997.1121 Yang, 2002, Differential expression of cytokines (IL-2, IFN-gamma, IL-10) and adhesion molecules (VCAM-1, LFA-1, CD44) between spleen and lymph nodes associates with remission in chronic relapsing experimental autoimmune encephalomyelitis, Scand. J. Immunol., 56, 286, 10.1046/j.1365-3083.2002.01132.x Zaccone, 1999, The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease, Eur. J. Immunol., 29, 1933, 10.1002/(SICI)1521-4141(199906)29:06<1933::AID-IMMU1933>3.0.CO;2-3 Zamvil, 1990, The T lymphocyte in experimental allergic encephalomyelitis, Annu. Rev. Immunol., 8, 579, 10.1146/annurev.iy.08.040190.003051 Zhang, 2003, Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system, J. Immunol., 170, 2153, 10.4049/jimmunol.170.4.2153 Zhang, 2004, IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells, Int. Immunol., 16, 249, 10.1093/intimm/dxh029